Abemaciclib in Real Clinical Practice of Adjuvant Therapy of HR+ HER2- High-Risk Breast Cancer: Experience of Centers in Moscow. Вопр. онкол. 2025, 71 (3), OF-2319. https://doi.org/10.37469/0507-3758-2025-71-3-OF-2319.